Skip to main content
. 2020 Sep 24;15(9):e0239519. doi: 10.1371/journal.pone.0239519

Table 1. Demographics, co-morbidities, and duration of symptoms and hospitalization.

Deceased (n = 21) n Survivor (n = 69) n p value
Sex
Male 15 (71.4%) 21 43 (62.3%) 69 0.6
Age
Age (years)* 68.24 ± 19.21 21 56.94 ± 15.00 69 0.02
Durations
Symptoms to admission* 3.4 ± 3.8 12 6.9 ± 3.9 60 0.01
Number of days admitted* 12.6 ± 11.3 21 8.0 ± 3.6 65 0.08
Number of days in ICU* 9.1 ± 11.2 21 0.7 ± 2.5 65 0.003
Co-morbidities
COPD and asthma 2 (13%) 15 4 (7%) 60 0.6
Diabetes 5 (33%) 15 20 (33%) 60 >0.9
Hypertension 5 (33%) 15 24 (40%) 60 0.8
Ischemic heart disease 5 (33%) 15 13 (22%) 60 0.3
Cerebrovascular disease 0 (0%) 15 1 (2%) 60 >0.9
Malignancy 1 (7%) 15 0 (0%) 60 0.2
Chronic renal disease 0 (0%) 15 2 (3%) 60 >0.9
Immunodeficiency 2 (13%) 15 3 (5%) 60 0.3
Autoimmune disease 1 (7%) 15 0 (0%) 60 0.2

*Two tailed unpaired Student’s t test with Welch correction. Otherwise, Fischer exact test.